Skip to main content
Blackhawk Growth Corp. logo

Blackhawk Growth Corp. — Investor Relations & Filings

Ticker · BLR ISIN · CA09238B3083 LEI · 875500A5R3SVGXL39M70 CSE Financial and insurance activities
Open in API
Filings indexed 574 across all filing types
Latest filing 2020-09-04 Regulatory Filings
Country CA Canada
Listing CSE BLR

About Blackhawk Growth Corp.

https://www.blackhawkgrowthcorp.com/

Blackhawk Growth Corp. operates as an investment issuer, specializing in generating shareholder value through strategic investments in the technology and life sciences sectors. The company focuses on acquiring and developing assets, intellectual property, and projects related to medical technologies, pharmaceuticals, digital health, software, big data, and AI. Blackhawk seeks opportunities that demonstrate global scalability and potential for positive impact on health and human wellbeing. Its core strategy involves providing capital for R&D and commercialization, followed by value realization through mergers, acquisitions, divestments, or spin-outs and public listings on North American stock exchanges.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 51-102F3 Material Change Report' and details a material change involving a distribution agreement for COVID-19 test kits. It includes specific dates, company information, and a full description of the material change. The form 51-102F3 is a regulatory filing used in Canadian securities regulation to disclose material changes. The document is not an annual or quarterly report, audit report, or earnings release. It is a formal disclosure of a material change event, which fits the category of Regulatory Filings (RNS) as it does not fit into more specific categories like capital updates or management changes. The document length (8199 characters) and content confirm it is a full material change report, not just an announcement of a report publication.
2020-09-04 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that Blackhawk Growth Corp. has entered into a definitive distribution agreement to distribute certain COVID-19 test kits. It details the terms of the distribution agreement, the products involved, regulatory approvals (FDA Emergency Use Authorization), and the company's plans and commitments. There are no financial statements, quarterly or annual results, or detailed financial data. The document is an announcement of a business agreement related to product distribution and does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a regulatory filing or certification. The content is primarily about a capital or business update related to distribution rights and agreements, which aligns best with Capital/Financing Update (CAP).
2020-09-04 English
Notice.pdf
Regulatory Filings
2020-08-19 English
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings Classification · 100% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' and references the British Columbia Securities Commission (BCSC) with a specific reference number. This form is a regulatory filing used to report exempt distributions of securities, typically related to private placements or exempt offerings. The content includes issuer information, underwriter details, and industry classification, which are typical for a regulatory compliance report rather than a financial performance report or announcement. There is no indication of financial statements, earnings data, management discussion, or shareholder meeting materials. The document is a regulatory compliance filing related to securities distribution, which fits best under the category of Regulatory Filings (RNS).
2020-08-14 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 51-102F3 Material Change Report filed by Blackhawk Growth Corp. It provides detailed information about a material change including an update on investment, financial figures for Q1 2020 (unaudited), shares issued for debt settlement, and stock option grants. The document is a regulatory filing specifically reporting a material change event rather than a full financial report or earnings release. It is not an announcement of a report publication but a substantive disclosure of a corporate event. This fits the category of Regulatory Filings (RNS) as it does not match other more specific categories like earnings release or capital update, and it is a formal regulatory disclosure form.
2020-08-11 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a corporate announcement providing an update on Blackhawk Growth Corp's investment in SAC Pharma Partners Inc., including unaudited Q1 financial figures, operational updates, and strategic plans. It also announces shares issued for debt settlement and stock option grants. The content is primarily an update on financing and capital structure changes (shares for debt settlement and stock options), rather than a full financial report or earnings release. There is no comprehensive financial statement or detailed quarterly report, nor is it a transcript or AGM material. The focus on shares issued for debt settlement and stock options aligns with Capital/Financing Update filings. The document length (6023 characters) supports it being a detailed announcement rather than a brief notice. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2020-08-11 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.